Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients.
about
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer.Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy.A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979)Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyRe-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.Ophthalmic vehicles containing polymer-solubilized tropicamide: "in vitro/in vivo" evaluation.Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
P2860
Q25257484-FA17DB0E-B7B4-4779-89FA-CC42370875CDQ33433212-F187D50A-05D4-44B3-9130-3D462102F59CQ35166688-7213B1DC-DB40-4B0C-85AE-EE9318821B19Q35825630-03C975AE-7A67-47E9-8493-73EA7827CCDDQ36388079-CCC2DAC8-42E9-4AA9-AA40-E8448EF854B4Q38205153-A6F3CFF2-28AC-4E4C-BC9F-D984873A6945Q43891199-03A27C64-BB2E-41A6-B03A-26DDFAC53DA8Q45917628-9F06FFB7-4EBB-4F99-94BB-2CAE280B72B7Q46811884-5087139B-5C43-4AA8-984F-1E978A9CEC8EQ47621457-DF0EE1EB-3AF1-4F03-A258-F2C2B4B55CECQ50205188-0E5A9283-440B-4072-8DA3-E0D7B23DDEEDQ51460131-4050B80C-3374-43ED-9CA9-67FD42572B9A
P2860
Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inter-relationships of paclita ...... L kinetics in cancer patients.
@ast
Inter-relationships of paclita ...... L kinetics in cancer patients.
@en
type
label
Inter-relationships of paclita ...... L kinetics in cancer patients.
@ast
Inter-relationships of paclita ...... L kinetics in cancer patients.
@en
prefLabel
Inter-relationships of paclita ...... L kinetics in cancer patients.
@ast
Inter-relationships of paclita ...... L kinetics in cancer patients.
@en
P2093
P1433
P1476
Inter-relationships of paclita ...... L kinetics in cancer patients.
@en
P2093
Sparreboom A
van Zuylen L
P304
P356
10.1097/00001813-200006000-00003
P577
2000-06-01T00:00:00Z